Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Researchers succeed in mapping the structure of virus that causes diarrhea

Researchers succeed in mapping the structure of virus that causes diarrhea

Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine

Cellid, IVI sign research service contract to evaluate immunogenicity of COVID-19 vaccine

Researchers identify adenovirus gene therapy for placental insufficiency

Researchers identify adenovirus gene therapy for placental insufficiency

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

The intranasal route of immunization may offer effective protection against SARS-CoV-2

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Oxford University and AstraZeneca release their COVID-19 vaccine results

Oxford University and AstraZeneca release their COVID-19 vaccine results

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

Researchers use machine learning algorithm to identify common respiratory pathogens

Researchers use machine learning algorithm to identify common respiratory pathogens

VA joins Pentagon in recruiting volunteers for COVID vaccine trials

VA joins Pentagon in recruiting volunteers for COVID vaccine trials

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Booster dose enhances immunogenicity of ChAdOx1 SARS-CoV-2 vaccine in aged mice

Booster dose enhances immunogenicity of ChAdOx1 SARS-CoV-2 vaccine in aged mice

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Scientists uncover important disease-fighting role for cells in the liver

Scientists uncover important disease-fighting role for cells in the liver

The COVID-19 vaccine pipeline

The COVID-19 vaccine pipeline

COVID-19 vaccine candidate shows potent immune response

COVID-19 vaccine candidate shows potent immune response